| International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ... Journal of thoracic oncology 6 (2), 244-285, 2011 | 6202 | 2011 |
| Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival J Takamizawa, H Konishi, K Yanagisawa, S Tomida, H Osada, H Endoh, ... Cancer research 64 (11), 3753-3756, 2004 | 3419 | 2004 |
| A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation Y Hayashita, H Osada, Y Tatematsu, H Yamada, K Yanagisawa, ... Cancer research 65 (21), 9628-9632, 2005 | 2166 | 2005 |
| p53: a frequent target for genetic abnormalities in lung cancer T Takahashi, MM Nau, I Chiba, MJ Birrer, RK Rosenberg, M Vinocour, ... Science 246 (4929), 491-494, 1989 | 1610 | 1989 |
| Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications T Kosaka, Y Yatabe, H Endoh, H Kuwano, T Takahashi, T Mitsudomi Cancer research 64 (24), 8919-8923, 2004 | 1598 | 2004 |
| Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non–small-cell lung cancer with postoperative … T Mitsudomi, T Kosaka, H Endoh, Y Horio, T Hida, S Mori, S Hatooka, ... Journal of Clinical Oncology 23 (11), 2513-2520, 2005 | 1196 | 2005 |
| Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas T Hida, Y Yatabe, H Achiwa, H Muramatsu, K Kozaki, S Nakamura, ... Cancer research 58 (17), 3761-3764, 1998 | 1162 | 1998 |
| Reduced expression of Dicer associated with poor prognosis in lung cancer patients Y Karube, H Tanaka, H Osada, S Tomida, Y Tatematsu, K Yanagisawa, ... Cancer science 96 (2), 111-115, 2005 | 841 | 2005 |
| Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling Y He, K Kozaki, T Karpanen, K Koshikawa, S Yla-Herttuala, T Takahashi, ... Journal of the National Cancer Institute 94 (11), 819-825, 2002 | 724 | 2002 |
| Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. I Chiba, T Takahashi, MM Nau, D D'Amico, DT Curiel, T Mitsudomi, ... Oncogene 5 (10), 1603-1610, 1990 | 675 | 1990 |
| Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis H Nagai, Y Okazaki, SH Chew, N Misawa, Y Yamashita, S Akatsuka, ... Proceedings of the national academy of sciences 108 (49), E1330-E1338, 2011 | 564 | 2011 |
| Vascular endothelial cell growth factor receptor 3–mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels Y He, I Rajantie, K Pajusola, M Jeltsch, T Holopainen, S Yla-Herttuala, ... Cancer research 65 (11), 4739-4746, 2005 | 560 | 2005 |
| Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 H Matsubara, T Takeuchi, E Nishikawa, K Yanagisawa, Y Hayashita, ... Oncogene 26 (41), 6099-6105, 2007 | 483 | 2007 |
| Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines T Hida, K Kozaki, H Muramatsu, A Masuda, S Shimizu, T Mitsudomi, ... Clinical Cancer Research 6 (5), 2006-2011, 2000 | 476 | 2000 |
| TTF-1 expression in pulmonary adenocarcinomas Y Yatabe, T Mitsudomi, T Takahashi The American journal of surgical pathology 26 (6), 767-773, 2002 | 475 | 2002 |
| Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases K Ishigaki, M Akiyama, M Kanai, A Takahashi, E Kawakami, H Sugishita, ... Nature genetics 52 (7), 669-679, 2020 | 461 | 2020 |
| Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas H Achiwa, Y Yatabe, T Hida, T Kuroishi, K Kozaki, S Nakamura, M Ogawa, ... Clinical Cancer Research 5 (5), 1001-1005, 1999 | 452 | 1999 |
| Prognostic Significance of p53 Mutations and 3p Deletions in Primary Resected Non-Small Cell Lung Cancer Y Horio, T Takahashi, T Kuroishi, K Hibi, M Suyama, T Niimi, K Shimokata, ... Cancer research 53 (1), 1-4, 1993 | 434 | 1993 |
| Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis T Mitsudomi, N Hamajima, M Ogawa, T Takahashi Clinical Cancer Research 6 (10), 4055-4063, 2000 | 420 | 2000 |
| Development of Antibodies against p53 in Lung Cancer Patients Appears to Be Dependent on the Type of p53 Mutation SF Winter, JD Minna, BE Johnson, T Takahashi, AF Gazdar, DP Carbone Cancer Research 52 (15), 4168-4174, 1992 | 404 | 1992 |
